Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
- Conditions
- Cardiovascular Disease
- Interventions
- Behavioral: Vivo Heart
- Registration Number
- NCT05972850
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
This pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical function, cognition, quality of life, stress, fatigability, physical activity, and aging biomarkers (Aim 2).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- 60 - 80 years
- Lives in a rural area based on established urban-rural definitions (e.g., RUCA codes, RUCC, UIC)
- A qualifying Cardio Vascular Disease (CVD) event or procedure
- Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m ≥32)
- No major depressive symptoms Patient Health Questionnaire (PHQ-8 <10)
- Ambulatory and community-dwelling
- Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month
- Medically cleared for exercise if event was within the last 6 months
- Access to a tablet or computer and internet/Wi-Fi in defined exercise space
- Able to provide own transportation to study visits
- Not participating in a clinical trial
- Willing to provide informed consent
- <60 years or >80 years
- Lives in non-rural area
- No CVD or a qualifying event or procedure
- Dementia or severe cognitive impairment (TICS-m <32)
- Clinical depression (PHQ-8 ≥10)
- Non-ambulatory, institutionalized, or requires walker
- Regular aerobic or resistance exercise (including current participation in a cardiac rehab program)
- Not medically cleared for exercise
- Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months
- Insulin-dependent diabetes
- Use of any supplemental oxygen for COPD
- Significant impairment from a prior stroke
- Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia)
- Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently
- Cancer (not including non-melanoma skin cancers) requiring treatment with the past year
- Excessive alcohol consumption (>7/week alcoholic beverages for women and >14/week for men) in the past month
- Joint replacement or other orthopedic surgery in past 12 months or planned in next 6 months
- No computer, tablet or internet access
- No access to transportation for travel to study visits
- Current participation in a clinical trial
- Inability or unwillingness to comply with the study requirements
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Vivo Heart Vivo Heart This virtual intervention will include weekly group exercise sessions with a Vivo trainer (2 times/week), weekly health education classes with a registered dietitian (RD) (1 time/week), and two individual meetings with the RD over the course of 12 weeks. Participants will also be asked to complete a weekly aerobic exercise session on their own (1 time/week).
- Primary Outcome Measures
Name Time Method Completion Rate Week 12 Completion rate which will be determined by the percentage of enrolled participants who complete the study with ≥80% compliance.
- Secondary Outcome Measures
Name Time Method Compliance Rate Week 12 Compliance will be determined based on adherence to the prescribed intervention. Compliance metrics will include attendance at the exercise sessions, health education classes, and dietary counseling sessions.
Satisfaction Survey Scores Week 12 Acceptability will be assessed at the end of the study using a program satisfaction survey.
Continuation Rate Year 1 Uptake will be determined by the number of participants who continue in the Vivo program after the study is over.
Retention Rate Week 12 Retention will be determined by the percentage of enrolled participations who complete follow-up testing.
Recruitment Rate Year 1 Recruitment rate will be determined by the total number of enrolled participants divided by the number of months recruitment occurred.
Recruitment Yield Year 1 Recruitment yield will be determined based on the number of participants randomized relative to the total number of volunteers screened
Trial Locations
- Locations (1)
Wake Forest University Health Sciences
🇺🇸Winston-Salem, North Carolina, United States